Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Prevalence of BRCA1 and BRCA2 gene mutations in Chinese patients with high-risk breast cancer.

Wang X, Liu H, Maimaitiaili A, Zhao G, Li S, Lv Z, Wu D, Shi A, Guan X, Jia H, Li M, Song D, Kang L, Han B, Fu T, Yang M, Zhu Z, Du Y, Song Y, Hong J, Fan Z.

Mol Genet Genomic Med. 2019 Jun;7(6):e677. doi: 10.1002/mgg3.677. Epub 2019 Apr 9.

2.

Erratum to Analysis of factors related to non-sentinel lymph node metastasis in 296 sentinel lymph node-positive Chinese breast cancer patients.

Maimaitiaili A, Wu D, Liu Z, Liu H, Muyiduli X, Fan Z.

Cancer Biol Med. 2018 Nov;15(4):478. doi: 10.20892/j.issn.2095-3941.2018.0438. No abstract available.

3.

[Normalization in axillary lymph node management after neoadjuvant therapy for breast cancer].

Wu D, Liu SY, Amina M, Fan ZM.

Zhonghua Wai Ke Za Zhi. 2019 Feb 1;57(2):97-101. doi: 10.3760/cma.j.issn.0529-5815.2019.02.005. Chinese.

PMID:
30704211
4.

Analysis of factors related to non-sentinel lymph node metastasis in 296 sentinel lymph node-positive Chinese breast cancer patients.

Maimaitiaili A, Wu D, Liu Z, Liu H, Muyiduli X, Fan Z.

Cancer Biol Med. 2018 Aug;15(3):282-289. doi: 10.20892/j.issn.2095-3941.2018.0023. Erratum in: Cancer Biol Med. 2018 Nov;15(4):478.

Supplemental Content

Loading ...
Support Center